The calcipotriol dose-irritation relationship: 48 hour occlusive testing in healthy volunteers using Finn Chambersρ

British Journal of Dermatology

Volumn 138, Issue 2, 1998, Pages 259-265

  Fullerton, A ^a   Benfeldt, E ^b   Petersen, J Roed ^b   Jensen, S Birk ^c   Serup, J ^a  

^a Leo Pharmaceutical Products ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSORIASIS; SCORING SYSTEM; SKIN BLOOD FLOW; SKIN IRRITATION; SKIN TEST;

ADOLESCENT; ADULT; AGED; CALCITRIOL; DERMATITIS, IRRITANT; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN; SKIN TESTS;

EID: 0031915006     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02071.x     Document Type: Article

References (20)

1. Kragballe K, Gjerten BT, DeHoope D et al. Double-blind, right-left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337: 193-6.
2. Cunliffe WJ, Berth-Jones J, Claudy A et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26: 736-43.
3. Berth-Jones J, Chu AC, Dodd WAH et al. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992; 127: 266-71.
4. Ramsay CA, Berth-Jones J, Brundin G et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260-4.
5. 3 analogue. Contact Dermatitis 1991; 25: 139-170.
6. Bruynzeel DP, Hol CW, Nieboer C. Allergic contact dermatitis to calcipotriol. Br J Dermatol 1992; 127: 66.
7. Steinkjer B. Contact dermatitis from calcipotriol. Contact Dermatitis 1994; 31: 122.
8. De Groot AC. Contact allergy to calcipotriol. Contact Dermatitis 1994; 30: 242-3.
9. Schmid P. Allergisches Kontaktekzem auf Calcipotriol. Akt Dermatol 1995; 21: 401-2.
10. Molin L. Contact dermatitis after calcipotriol and patch test evaluation (letter). Acta Derm Venereol (Stockh) 1996; 76: 163-4.
11. Garcia-Bravo B, Camacho F. Two cases of contact dermatitis caused by calcipotriol cream. Am J Contact Dermatitis 1996; 7: 118-9.
12. Fullerton A, Avnstorp C, Agner T et al. Patch lest study with calcipotriol ointment in different patient groups, including psoriatic patients with and without adverse dermatitis. Acta Derm Venereol (Stockh) 1996; 76: 194-202.
13. Fullerton A, Serup J. Characterization of irritant patch test reactions to topical D-vitamins and all-trans retinoic acid in comparison with SLS. Br J Dermatol 1997; 137: 234-40.
14. Alexander S. Patch testing and menstruation (letter). Lancet 1989; 2: 751.
15. Agner T, Damm P, Skouby SO. Menstrual cycle and skin reactivity. J Am Acad Dermatol 1991; 24: 566-70.
16. Wärdell K. Laser Doppler perfusion imaging. Methodology and skin applications. Linköping Studies in Science and Technology Dissertations, thesis 329. Linköping, 1994.
17. Fullerton A, Fischer T, Lahti A et al. Guidelines for measurement of skin colour and erythema. A report from the standardization group of the European Society of Contact Dermatitis. Contact Dermatitis 1996; 35: 1-10.
18. Agner T. Basal transepidermal water loss, skin thickness, skin blood flow and skin colour in relation to sodium lauryl sulphate induced irritation in normal skin. Contact Dermatitis 1991; 25: 108-14.
19. Hayakawa R, Suzuki M, Fujimoto Y. Results of dermal safety study of MC 903 ointment incorporated with an active vitamin D analogue. Skin Res 1993; 35: 109-16.
20. Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis 1986; 14: 221-7.